Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Glaxosmithkline Plc LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  14.00 1.02% 1,380.00 1,378.80 1,379.20 1,379.80 1,357.80 1,371.00 11,901,964 16:35:17
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 33,754.0 6,221.0 93.9 14.7 69,240

Glaxosmithkline Share Discussion Threads

Showing 19026 to 19050 of 23025 messages
Chat Pages: Latest  765  764  763  762  761  760  759  758  757  756  755  754  Older
DateSubjectAuthorDiscuss
05/2/2019
12:26
Monty...there is no chance of increased dividend. That would be reckless. We need to seriously invest in innovative drug discovery. Interesting situation developing between NHS and Vertex about cystic fibrosis drug.
zicopele
05/2/2019
12:15
Everyone expecting 23p quarterly dividend to be announced tomorrow.But if they happens to increase to 24p div tomorrow, wow shares would take off.
montyhedge
05/2/2019
12:10
Emma is really trying to wake up this giant snail of a company - where it will lead I am not sure - hopefully towards innovation, growth and a higher share price.
nimbo1
05/2/2019
10:30
All being well, surely must see 1525p.With a 23p dividend in the bag is my opinion.
montyhedge
05/2/2019
09:22
Figures should be ok, all depends on Walmsley forward looking statement. 23p quarterly dividend in the bag.
montyhedge
05/2/2019
08:42
If some said generic version 10 pounds or original version 10 pounds, what would you buy.
montyhedge
04/2/2019
19:04
Everyone acting has if that's it, no more Advair sales, they will compete with the sales team they have, that surely will dampen the generic version. I would want the real thing if it was me.
montyhedge
04/2/2019
17:51
The point I'm trying to make is a shingles vaccine will not transform prospects for GSK, as Advair did, as Zantac did before that. It does help.
essentialinvestor
04/2/2019
17:47
No point speculating until Wednesday all will be revealed. There will still be sales of Advair in the future, just match generic prices. I know I would have the real thing, rather than a generic version for the sesame money. 23p dividend will be in the bag though.
montyhedge
04/2/2019
17:42
Essential...we are comparing 2018 go 2019. Advair fell off a cliff in terms of sales last year and it's demise will be almost complete this year.
zicopele
04/2/2019
17:33
In 2017 Advair was still earning 4 Billion USD in annual revenue, annual revenue!. There is no comparison between the 2 for multiple reasons.
essentialinvestor
04/2/2019
16:27
We need more turnover. Shingrix will be significantly bigger than last year but cost of production will be higher than Advair.
zicopele
04/2/2019
16:15
Wednesday will reveal all.
montyhedge
04/2/2019
13:07
Haha Monty.. sure you do. All of this is in the price. I only hope they cut the dividend guidance and pump drug discovery. £2bn per annum would buy a lot of research.
zicopele
04/2/2019
11:10
I think on Wednesday after figures GSK will break out to the upside, looking for 1560p. Results should be good with a quarterly dividend of 23p.
montyhedge
04/2/2019
08:58
This feels like its been rangebound for ever and shows little sign of changing.Still better than constantly going down like some of my others (vod) !
tim 3
03/2/2019
11:52
Guessestimate the pre tax, apply a 20/22 multiple. That will take you somewhere near the figure, adjust for % ownership.
essentialinvestor
03/2/2019
10:38
Here's a project for someone good at numbers: GSK said it will hold a majority controlling interest in the new CH venture at 68 per cent, while Pfizer will retain an equity interest of the remaining 32 per cent. Within three years of closing the deal, GSK will break up the company into two separate businesses: one to be focused on consumer healthcare, and the other for pharmaceuticals and vaccines. It may also list the new venture in the UK. Once the value has been 'unlocked', can anyone speculate what the equivalent value would be to today's existing shareholders?
tradermichael
02/2/2019
09:30
Great tip for GSK today by Questor Daily Telegraph.
montyhedge
01/2/2019
17:19
My only hope is that we may unleash the animal instincts by demerging the company. Something akin to the old British Gas would be a success which I believe split three ways and all did prosper in time. BT also demerged into fixed line and mobile services. Maybe just maybe we have a giant that is finally awakening.
zicopele
01/2/2019
16:39
Yes, including dividends !
tradermichael
01/2/2019
16:24
patience has its rewards.
abdullla
01/2/2019
14:54
GSK has done nothing and gone nowhere for the last twenty years. The company is sclerotic. Even with the Pfizer deal and possible demerger, it has not budged. Very frustrating.....oh but we get the dividend...the gift which keeps giving blah blah but which is a noose around our necks.
zicopele
01/2/2019
11:31
Next quarterly dividend 23p.
montyhedge
01/2/2019
11:25
Erm ….. what year? Jan 2018 ~1300p Jan 2019 1400p = UP ~100p Jan 2019 ~1496p 1 Feb 2019 1486p = DOWN ~10p (INTRA DAY) ANNUAL DIVIDEND = 80P
tradermichael
Chat Pages: Latest  765  764  763  762  761  760  759  758  757  756  755  754  Older
ADVFN Advertorial
Your Recent History
LSE
GSK
Glaxosmith..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201125 02:46:08